Shares of GeneNews Ltd (TSE:GEN – Get Free Report) were up 7.1% during mid-day trading on Monday . The stock traded as high as C$0.15 and last traded at C$0.15. Approximately 473,147 shares changed hands during mid-day trading, a decline of 68% from the average daily volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Stock Performance
The company has a market cap of C$25.49 million and a PE ratio of -2.21. The business’s 50-day moving average price is C$0.15.
About GeneNews
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Read More
- Five stocks we like better than GeneNews
- 3 Ways To Invest In Coffee, Other Than Drinking It
- United Airlines Soars on Earnings Beat
- Learn Technical Analysis Skills to Master the Stock Market
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Stock Average Calculator
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.
